Guy Georges

USPTO Granted Patents = 71 (Patent Applications = 57)

CIPO Patents = 8 (Patent Applications = 31)

EPO Patents = 40 (Patent Applications = 73)

Average Co-Inventor Count = 6.9

ph-index = 9

Forward Citations = 371(Granted Patents)

Forward Citations (Not Self Cited) = 328(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Habach, DE (2003 - 2024)
Penzberg, DE (2023 - 2024)

Company Filing History:

62 out of 4,945

Hoffmann-la Roche Inc.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Areas of Expertise:

Multispecific Antibodies

Humanized Antibodies

Bispecific Antibodies

Tumor-Targeted Antibodies

Covalently Linked Conjugates

Anti-VEGF Antibodies

CD19 Antibodies

NKG2D Antibodies

Blood Brain Barrier Shuttles

HER3 Antigen Binding

Anti-ANG2 Antibodies

Disulfide-Linked Proteins

71 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297290 - Method for generating multispecific antibodies from monospecific antibodies (2025-05-13),

2. 12297263 - Humanized anti-Tau(PS422) antibodies and methods of use (2025-05-13),

3. 12252533 - Anti-transferrin receptor antibodies with tailored affinity (2025-03-18),

4. 12227594 - Bispecific 2+1 contorsbodies (2025-02-18),

5. 12215152 - Humanized anti-human CD19 antibodies and methods of use (2025-02-04),

6. 12145994 - Bispecific antigen binding molecules capable of specific binding to CD40 and to fap (2024-11-19),

7. 12103967 - Bispecific anti-CCL2 antibodies (2024-10-01),

8. 12043651 - Compbody—a multivalent target binder (2024-07-23),

9. 12023378 - Covalently linked antigen-antibody conjugates (2024-07-02),

10. 11827711 - Antibodies binding to NKG2D (2023-11-28),

11. 11820816 - Anti-VEGF antibodies and methods of use (2023-11-21),

12. 11787873 - Bispecific HER2 antibodies and methods of use (2023-10-17),

13. 11739142 - Bispecific anti-CCL2 antibodies (2023-08-29),

14. 11680110 - Three-dimensional structure-based humanization method (2023-06-20),

15. 11673968 - Anti-BRDU antibodies and methods of use (2023-06-13),

Title: Guy Georges: A Visionary Innovator Shaping the Future

Introduction: Guy Georges, a brilliant inventor hailing from Habach, Germany, has left an indelible mark on the world of innovation with his exceptional work.

Latest Patents: Among his impressive portfolio of 62 patents, Guy Georges' latest inventions include groundbreaking developments such as antibodies binding to NKG2D and Anti-VEGF antibodies, revolutionizing the fields of immunotherapy and disease treatment.

Career Highlights: Having worked at prestigious companies like Hoffmann-La Roche Inc., Guy Georges has consistently demonstrated his prowess in translating cutting-edge ideas into impactful solutions.

Collaborations: Throughout his career, Guy Georges has collaborated closely with esteemed professionals like Ekkehard Moessner and Olaf Mundigl, fostering a culture of innovation and excellence in his projects.

Conclusion: Guy Georges stands as a true pioneer in the realm of innovation, with a remarkable ability to bring visionary concepts to life, thereby positively influencing society and advancing the frontiers of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.